CFRX - ContraFect Corp
Close
0.2318
0.006 2.761%
Share volume: 214,233
Last Updated: Wed 08 Nov 2023 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.23
0.01
2.84%
Summary score
34%
Profitability
33%
Dept financing
20%
Liquidity
28%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
31.98%
Return on assets
-22.19%
Return on sales
0%
Return on invested capital
-1.97%
Total debt ratio
65.08%
Debt ratio change over timeo
-0.97%
Current Ratio
7.27%
Quick Ratio
0%
Cash Position Ratio
1.56%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-45.31%
Return on assets
-20.4%
Return on sales
0%
Return on invested capital
-15.78%
Total debt ratio
64.12%
Debt ratio change over timeo
-0.62%
Current Ratio
5.72%
Quick Ratio
0%
Cash Position Ratio
2.45%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
18.72%
Return on assets
-12.19%
Return on sales
0%
Return on invested capital
-384.88%
Total debt ratio
69.34%
Debt ratio change over time
-0.56%
Current Ratio
11.61%
Quick Ratio
0%
Cash Position Ratio
3.76%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.96%
Return on assets
-99.8%
Return on sales
0%
Return on invested capital
-67.25%
Total debt ratio
-96.61%
Debt ratio change over time
-0.97%
Current Ratio
0.27%
Quick Ratio
0%
Cash Position Ratio
-0.73%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | CFRX | VLON | ELAT | RETA |
---|---|---|---|---|
Return on equity | 31.98% | 0% | 0% | 26.83% |
Return on assets | -22.19% | 0% | 0% | -10.24% |
Return on sales | 0% | 0% | 0% | -1670.47% |
Return on invested capital | -1.97% | 0% | 0% | 57.71% |
Profitability | 50% | 0% | 25% | 46% |
Total debt ratio | 65.08% | 0% | 0% | 168.24% |
Debt ratio change over time | -0.97% | 0% | 0% | 17.84% |
Dept financing | 10% | 0% | 0% | 50% |
Current Ratio | 5.72% | 0% | 0% | 8.32% |
Quick Ratio | 0% | 0% | 0% | 8.32% |
Cash Position Ratio | 2.45% | 0% | 0% | 7.97% |
Liquididy | 34% | 0% | 0% | 66% |
Short-term ratios | CFRX | VLON | ELAT | RETA |
---|---|---|---|---|
Return on equity | -45.31% | 0% | 0% | -39.65% |
Return on assets | -20.4% | 0% | 0% | -13.45% |
Return on sales | 0% | 0% | 0% | -4352.39% |
Return on invested capital | -15.78% | 0% | 0% | 120.66% |
Profitability | 25% | 0% | 50% | 25% |
Total debt ratio | 64.12% | 0% | 0% | 65.53% |
Debt ratio change over time | -0.62% | 0% | 0% | 0.08% |
Dept financing | 24% | 0% | 0% | 50% |
Current Ratio | 5.72% | 0% | 0% | 8.32% |
Quick Ratio | 0% | 0% | 0% | 8.32% |
Cash Position Ratio | 2.45% | 0% | 0% | 7.97% |
Liquididy | 25% | 0% | 0% | 75% |